Mepidental (Mepivacaine Hydrochloride)

Mepivacaine works by reversibly binding to voltage‑gated sodium channels on nerve cells, stabilising them in an inactive state. This blocks sodium influx, preventing the initiation and propagation of nerve impulses, which results in a reversible loss of sensation in the area where the drug is applied.

The appropriate dose of Mepidental is determined by the prescribing clinician based on the specific procedure, patient characteristics and the required depth of anesthesia. Healthcare professionals calculate the volume and concentration needed to achieve effective analgesia while staying within safe limits.

The safety of mepivacaine in pregnancy or while breastfeeding has not been definitively established. Use during pregnancy or lactation should only be considered if the potential benefit justifies any potential risk, and it must be prescribed and monitored by a qualified healthcare provider.

To request Mepidental, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Mepivacaine offers a rapid onset of action and intermediate duration, similar to lidocaine but with slightly less vasodilatory effect, which may reduce the need for vasoconstrictors. Compared with bupivacaine, it has a shorter duration and lower cardiotoxic potential, making it suitable for shorter procedures.

Mepidental should be stored at room temperature, below 25 °C, in its original packaging. Protect the solution from direct sunlight, moisture and extreme temperatures. Do not freeze the product, and inspect the container for any signs of damage before use.

Mepidental is supplied as a sterile solution for injection. It is administered by infiltration directly into the tissue or by perineural injection adjacent to the target nerve. Proper aseptic technique, aspiration before injection and adherence to recommended concentrations are essential for safe use.

Serious risks include allergic reactions such as anaphylaxis, cardiac arrhythmias or conduction disturbances, central nervous system toxicity (e.g., seizures), and rare cases of methemoglobinemia. Immediate medical attention is required if any of these severe reactions occur.

Mepidental should not be used in patients with a known hypersensitivity to mepivacaine or other amide‑type local anesthetics, in individuals with severe cardiac conduction disorders without appropriate monitoring, or in patients where the risk of systemic toxicity outweighs the benefit of regional anesthesia.